Newborn affected by maternal use of drugs of addiction
ICD-10 P04.4 is a billable code used to indicate a diagnosis of newborn affected by maternal use of drugs of addiction.
P04.4 refers to newborns who are affected by maternal substance use, including drugs of addiction, alcohol, and tobacco. These substances can cross the placenta during pregnancy or be transmitted through breast milk, leading to various neonatal complications. Newborns may present with withdrawal symptoms, growth restrictions, or developmental delays. Common substances include opioids, benzodiazepines, alcohol, and nicotine. Clinical manifestations can range from mild irritability to severe withdrawal syndromes, necessitating careful monitoring and management in a neonatal intensive care unit (NICU). The long-term effects on neurodevelopment and behavior are also significant considerations for affected infants. Accurate coding requires comprehensive documentation of maternal substance use, the infant's clinical presentation, and any interventions provided.
Detailed maternal history, including substance use type, timing, and quantity, as well as newborn assessment findings.
Newborns presenting with withdrawal symptoms, requiring pharmacological intervention or supportive care.
Consideration of the infant's gestational age and overall health status when assessing the impact of maternal substance use.
Comprehensive follow-up documentation on developmental milestones and any ongoing interventions related to maternal substance exposure.
Pediatric assessments of infants with a history of maternal drug use, focusing on growth and developmental outcomes.
Long-term monitoring for potential behavioral and cognitive issues stemming from prenatal exposure.
Used when assessing a newborn affected by maternal substance use.
Document maternal history and newborn assessment findings.
Neonatologists should ensure thorough documentation of withdrawal symptoms.
Common withdrawal symptoms include irritability, tremors, feeding difficulties, vomiting, and seizures. The severity and type of symptoms can vary based on the substance used by the mother.
